Provided is quinalonin compound of Formula (I) or a pharmaceutically acceptable salt or solvate thereof, substituted at positions 3 and /or 5 and with defined other substituents. The compound is a derivative of anagrelide, with improved properties and can be used to treat myeloproliferative diseases, high blood pressure and brondhodilation.